Akcea Therapeutics, Inc. Stock Split Ratio
Akcea Therapeutics, Inc. reported Stock Split Ratio of 39.14% for the 1-month period ending 2017-05-31, per its 10-K filed 2020-03-02.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2020-03-02
- 2017-05-31: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 39.14%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month |
|---|---|
| 2017-05-31 | 39.14% 10-K · filed 2020-03-02 |